Search Results

Danish Sonographers' Experiences of the Introduction of "Moderate Risk" in Prenatal Screening for Down Syndrome.

• Authors : Møller A; Department of Public Health, Aarhus University, Aarhus, Denmark.; Center for Fetal Diagnostics, Aarhus University Hospital, Aarhus, Denmark.

Subjects: Ultrasonography*; Down Syndrome/Down Syndrome/Down Syndrome/*diagnostic imaging ; Pregnancy/Pregnancy/Pregnancy/*psychology

• Source: Journal of pregnancy [J Pregnancy] 2018 Oct 09; Vol. 2018, pp. 1646035. Date of Electronic Publication: 2018 Oct 09 Publisher: Hindawi Pub. Corp Country of Publication: Egypt NLM ID: 101553823 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Phenomenology of pregnancy and the ethics of abortion.

• Authors : Svenaeus F; Centre for Studies in Practical Knowledge, Södertörn University, 141 89, Huddinge, Sweden. .

Subjects: Awareness*; Abortion, Induced/Abortion, Induced/Abortion, Induced/*ethics ; Pregnancy/Pregnancy/Pregnancy/*psychology

• Source: Medicine, health care, and philosophy [Med Health Care Philos] 2018 Mar; Vol. 21 (1), pp. 77-87.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9815900 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Abnormal folic acid-homocysteine metabolism as maternal risk factors for Down syndrome in Japan.

• Authors : Takamura N; Dept. of Public Health, Nagasaki University, Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan. .; Kondoh T

Subjects: Down Syndrome/Down Syndrome/Down Syndrome/*blood ; Folic Acid/Folic Acid/Folic Acid/*blood ; Homocysteine/Homocysteine/Homocysteine/*blood

• Source: European journal of nutrition [Eur J Nutr] 2004 Oct; Vol. 43 (5), pp. 285-7. Date of Electronic Publication: 2004 Jan 06.Publisher: Steinkopff Country of Publication: Germany NLM ID: 100888704 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1436-6207

Record details

Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy.

• Authors : Frendo JL; Institut National de la Santé et de la Recherche Médicale, U 427, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes, 75270 Paris, France.; Guibourdenche J

Subjects: Chorionic Gonadotropin/Chorionic Gonadotropin/Chorionic Gonadotropin/*biosynthesis ; Down Syndrome/Down Syndrome/Down Syndrome/*metabolism ; Pregnancy/Pregnancy/Pregnancy/*metabolism

• Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2004 Feb; Vol. 89 (2), pp. 727-32.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Print ISSN:

Record details

Down's syndrome screening with nuchal translucency at 12(+0)-14(+0) weeks and maternal serum markers at 14(+1)-17(+0) weeks: a prospective study.

• Authors : Rozenberg P; Poissy-Saint Germain Hospital, Centre hospitalier Poissy-Saint Germain, 10, rue de Champ Gaillard, 78303 Poissy Cédex, France. ; Malagrida L

Subjects: Down Syndrome/Down Syndrome/Down Syndrome/*diagnosis ; Neck/Neck/Neck/*embryology ; Pregnancy/Pregnancy/Pregnancy/*blood

• Source: Human reproduction (Oxford, England) [Hum Reprod] 2002 Apr; Vol. 17 (4), pp. 1093-8.Publisher: Oxford University Press Country of Publication: England NLM ID: 8701199 Publication Model: Print Cited Medium: Print ISSN: 0268-1161

Record details

Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.

• Authors : Spencer K

Subjects: Chorionic Gonadotropin, beta Subunit, Human/Chorionic Gonadotropin, beta Subunit, Human/Chorionic Gonadotropin, beta Subunit, Human/*blood ; Down Syndrome/Down Syndrome/Down Syndrome/*diagnosis ; Pregnancy/Pregnancy/Pregnancy/*blood

• Source: Annals of clinical biochemistry [Ann Clin Biochem] 2001 Jul; Vol. 38 (Pt 4), pp. 413-4.Publisher: Sage Country of Publication: England NLM ID: 0324055 Publication Model: Print Cited Medium: Print ISSN: 0004-5632 (Print) Linking

Record details

Cost and effectiveness of the California triple marker prenatal screening program.

• Authors : Cunningham GC; Genetic Disease Branch, California Department of Health Services, Berkeley, USA.; Tompkinison DG

Subjects: Cost-Benefit Analysis*; Biomarkers/Biomarkers/Biomarkers/*blood ; Chorionic Gonadotropin/Chorionic Gonadotropin/Chorionic Gonadotropin/*blood

• Source: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 1999 Jul-Aug; Vol. 1 (5), pp. 199-206.Publisher: Elsevier Country of Publication: United States NLM ID: 9815831 Publication Model: Print Cited Medium: Print ISSN: 1098-3600 (Print)

Record details

Does screening for Down's syndrome cause anxiety in pregnant women? A systematic review.

• Authors : Lou S; CFK - Public Health & Quality Improvement, Central Denmark Region, Aarhus, Denmark; Institute of Public Health, Aarhus University, Aarhus, Denmark.

Subjects: Anxiety/Anxiety/Anxiety/*physiopathology ; Down Syndrome/Down Syndrome/Down Syndrome/*diagnosis ; Maternal Welfare/Maternal Welfare/Maternal Welfare/*psychology

• Source: Acta obstetricia et gynecologica Scandinavica [Acta Obstet Gynecol Scand] 2015 Jan; Vol. 94 (1), pp. 15-27. Date of Electronic Publication: 2014 Sep 21.Publisher: Wiley Country of Publication: United States NLM ID: 0370343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0412

Record details

The effectiveness of non-invasive prenatal test technology and the prenatal screening algorithm based on various methods for determining foetal aneuploidy.

• Authors : Sadvakassova, Leila¹; Kurmangali, Zhanar² ; Beloussov, Vyacheslav³

• Source: Journal of the Turkish-German Gynecological Association. Sep2023, Vol. 24 Issue 3, p152-158. 7p.

Record details

Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening.

• Authors : Heinonen S; Department of Obstetrics and Gynecology, University Hospital of Kuopio, Finland.; Ryynänen M

Subjects: Fertilization in Vitro*; Chorionic Gonadotropin/Chorionic Gonadotropin/Chorionic Gonadotropin/*blood ; Down Syndrome/Down Syndrome/Down Syndrome/*diagnosis

• Source: Fertility and sterility [Fertil Steril] 1996 Sep; Vol. 66 (3), pp. 398-403.Publisher: Elsevier for the American Society for Reproductive Medicine Country of Publication: United States NLM ID: 0372772 Publication Model: Print Cited

Record details